China has inoculated hundreds of thousands of essential workers and other groups considered at high risk with other vaccines.- AFP
BEIJING (Reuters): A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical trial, researchers said.
In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group's experimental shot showed no severe adverse reactions, its researchers said on Tuesday (Oct 6) in a paper posted on medRxiv preprint server ahead of peer review.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
